At the intersection of biotech and hospitality, The Ritz-Carlton Spa Singapore has become Southeast Asia's first luxury spa to offer EPICUTIS®, a pharmaceutical-grade skincare line born from Princeton biophysics and medical-grade formulation science. The partnership, unveiled in November 2025, reflects a quiet but significant evolution in how luxury properties understand wellness — no longer as mere indulgence, but as a discipline grounded in clinical evidence and measurable human benefit. In choosing Singapore as its regional flagship, EPICUTIS® and The Ritz-Carlton together suggest that the
Ritz-Carlton Singapore Debuts EPICUTIS® Skincare in Southeast Asia Expansion
Wellness backed by science is increasingly embraced as essential to modern luxury
Mark
So this is a press release about a skincare brand launching at a hotel spa. What makes this story worth reading?
Mimi
It's not really about skincare, actually. It's about how luxury hotels are redefining what luxury means. Ten years ago, a spa was just a place to get a massage. Now it's a place where science meets pampering—where guests expect results, not just relaxation.
Luke
But we should be clear: this is a press release. Everything here comes from the hotel and the skincare company. We don't have independent verification that these ingredients actually do what they claim.
Mimi
That's fair. But the ingredients are real—TSC, Hyvia®, DSD—they're patented compounds developed at Signum Biosciences. The EWG Verification is a real third-party certification.
Luke
Yes, but EWG Verified means the ingredients are non-toxic. It doesn't mean the skincare actually reduces wrinkles or strengthens barriers the way the press release suggests. Those are claims made by the company.
Mark
So why did the Ritz-Carlton choose this brand over others?
Mimi
Because it fits a narrative they want to tell about themselves. The hotel's general manager says they're anticipating guests' "unspoken needs." That's code for: we're positioning ourselves as forward-thinking, science-driven, not just luxurious.
Luke
And Singapore is a smart choice for a launch. It's wealthy, it's tech-forward, it's a hub for medical tourism. The brand gets credibility by association.
Mark
What about the actual guest experience? What are people paying for?
Mimi
Five different facial treatments, each designed for different skin concerns. A full-body lipid treatment. A pregnancy-safe ritual. The spa has ten treatment rooms, whirlpools, steam rooms, Zero Gravity recliners. It's the full luxury wellness package.
Luke
But we don't know the pricing. We don't know how many guests have actually tried these treatments or what they think. This is the announcement, not the outcome.
Mark
Fair point. So what's the real story here?
Mimi
It's about how luxury is changing. Guests don't just want to feel pampered anymore—they want to feel like they're investing in their health. Science gives that permission.
Luke
And hotels are betting that combining luxury with clinical credibility will justify higher prices and attract a specific kind of guest: wealthy, educated, skeptical of marketing, but willing to pay for something that sounds scientifically sound.
Mark
Even if the science isn't independently verified?
Luke
Especially then. Because the guest can't verify it either. They're buying the story and the experience. The science is just the story's foundation.
The Pulse
- Luxury hospitality is under pressure to move beyond aesthetics — guests now expect treatments with clinically proven, lasting results, not just momentary relaxation.
- EPICUTIS® enters Southeast Asia with a disruptive proposition: pharmaceutical-grade skincare ingredients, including patented molecules targeting the skin barrier, cellular hydration, and UV damage, brought directly into the spa setting.
- The Ritz-Carlton positions itself ahead of regional competitors by securing exclusive flagship status for the brand, signaling a strategic bet that science-backed wellness will define the next era of luxury.
- Five bespoke treatment offerings — from pregnancy-safe rituals to full-body lipid therapies — translate complex biotech research into accessible, personalized guest experiences.
- The partnership is already landing as a marker of industry direction: integrative health and measurable efficacy are becoming the new standard by which luxury spas will be judged.
At the intersection of biotech and hospitality, The Ritz-Carlton Spa Singapore has become Southeast Asia's first luxury spa to offer EPICUTIS®, a pharmaceutical-grade skincare line born from Princeton biophysics and medical-grade formulation science. The partnership, unveiled in November 2025, reflects a quiet but significant evolution in how luxury properties understand wellness — no longer as mere indulgence, but as a discipline grounded in clinical evidence and measurable human benefit. In choosing Singapore as its regional flagship, EPICUTIS® and The Ritz-Carlton together suggest that the future of luxury living is one where science and serenity are no longer separate pursuits.
The Ritz-Carlton Spa Singapore has quietly made history, becoming the first luxury spa in Southeast Asia to introduce EPICUTIS®, a skincare line that applies pharmaceutical research technologies to topical formulations. Developed by Princeton biophysicist Dr. Jeffry Stock alongside master formulator Masanori Tamura, the brand is built around three patented ingredients — TSC for barrier reinforcement, Hyvia® for cellular-level fatty acid delivery derived from organic chia seed oil, and DSD for antioxidant protection against UV and pollution. Every product meets EWG Verification standards and is processed to medical-grade purity.
The hotel's General Manager, Peter Mainguy, described the collaboration as a response to evolving guest expectations — an effort to anticipate needs before they are voiced. Maxwell Stock, EPICUTIS® CEO, called Singapore the ideal gateway into the region, citing its identity as a hub of innovation and culture. Together, they frame the partnership not as a commercial arrangement but as a new chapter in what luxury wellness can mean.
The spa's treatment menu now includes five signature offerings: a Bespoke Facial tailored to individual skin profiles, a Signature Facial targeting brightness and barrier strength, a Brightening Facial rich in antioxidant actives, a pregnancy-safe Mom-to-Be Ritual, and a Lipid Full Body Treatment combining lymphatic drainage, exfoliation, and deep nourishment. These are delivered within a serene Level One sanctuary overlooking Marina Bay, across ten treatment rooms, a couples' suite, and facilities including whirlpools, steam rooms, saunas, and Zero Gravity recliners.
The broader implication is clear: luxury hospitality is recalibrating its relationship with wellness, shifting from indulgence toward integration — where clinical science and holistic care are no longer in tension, but in service of the same guest.
The Ritz-Carlton Spa Singapore has become the first luxury spa in Southeast Asia to offer EPICUTIS®, a pharmaceutical-grade skincare line developed by biotech company Signum Biosciences. The partnership, announced in November, designates the hotel's spa as the brand's flagship property across the region—a move that signals a broader shift in how luxury hospitality is approaching wellness.
EPICUTIS® was created by Dr. Jeffry Stock, a Princeton biophysicist, in collaboration with master formulator Masanori Tamura. The line applies pharmaceutical research technologies to topical skincare formulations, a first for professional beauty products. The brand's approach centers on what it calls a "science-first philosophy," built around three proprietary patented ingredients: TSC, a molecule designed to strengthen skin's natural barrier against environmental damage; Hyvia®, derived from organic chia seed oil and formulated to deliver omega-3 and omega-6 fatty acids at the cellular level; and DSD, an antioxidant meant to protect against UV and pollution-induced skin damage. Every product carries EWG Verification and is made with non-toxic ingredients processed to medical-grade purity standards.
Peter Mainguy, General Manager of The Ritz-Carlton, Millenia Singapore, framed the partnership as a response to changing guest expectations. He noted that the hotel is committed to anticipating what guests need—often before they articulate it themselves—and that this collaboration marks a new chapter in luxury wellness for Southeast Asia, one where cutting-edge skincare science meets holistic well-being. Maxwell Stock, Founder and CEO of EPICUTIS®, emphasized Singapore's role as a hub of innovation and culture, calling it the ideal gateway for the brand's expansion into the region.
The spa's signature offerings include five main treatments. A Bespoke Facial tailors pharmaceutical-grade formulations to individual skin needs. The Signature Facial uses EPICUTIS® patented ingredients to brighten complexion while strengthening the skin barrier. A Brightening Facial targets dull skin with antioxidant-rich actives. For pregnant guests, a Mom-to-Be Ritual offers pregnancy-safe treatment designed to calm inflammation and promote skin elasticity. A Lipid Full Body Treatment combines lymphatic drainage, exfoliation, and deep nourishment across the entire body.
The Ritz-Carlton Spa itself occupies a tranquil setting on Level One of the hotel, nestled among lush greenery with an outdoor swimming pool overlooking Marina Bay. The facility includes ten serene treatment rooms, a private spa suite for couples, and separate his-and-her locker rooms equipped with whirlpools, steam rooms, saunas, and Zero Gravity recliners. The spa operates daily from 9 a.m. to 9 p.m. and can be reached at (65) 6434-5203 or rc.sinrz.spa@ritzcarlton.com.
The partnership reflects a broader industry trend. As luxury hospitality increasingly embraces integrative health and holistic wellness, properties are moving beyond traditional spa offerings toward treatments backed by clinical evidence and measurable results. The Ritz-Carlton's decision to position itself as the region's first luxury spa featuring EPICUTIS® underscores how the brand sees wellness—not as indulgence alone, but as a science-backed essential component of modern luxury living. For guests seeking visible, lasting results rooted in both inner balance and outer radiance, the spa now offers a treatment menu designed to deliver exactly that.
Notable Quotes
We are committed to continuously innovating in anticipation of our guests' evolving and often unspoken needs. Our exclusive partnership with EPICUTIS® marks a new chapter in luxury wellness for Southeast Asia.— Peter Mainguy, General Manager, The Ritz-Carlton, Millenia Singapore
Singapore is a hub of innovation, culture, and luxury, making it the perfect gateway for EPICUTIS® into Southeast Asia.— Maxwell Stock, Founder & CEO of EPICUTIS®
Want the full story?
Read the original at Lokmat Times ↗
Health & Medicine